Influence of the vitreomacular interface on the efficacy of intravitreal therapy for uveitis-associated cystoid macular oedema

Marion R. Munk*, Radha Ram, Alfred W Rademaker, Dachao Liu, Vikram Setlur, Felix Chau, Ursula Schmidt-Erfurth, Debra Anne Goldstein

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

21 Scopus citations


Purpose To evaluate the effect of the vitreomacular interface (VMI) on treatment efficacy of intravitreal therapy in uveitic cystoid macular oedema (CME). Methods Retrospective analysis of CME resolution, CME recurrence rate and monthly course of central retinal thickness (CRT), retinal volume (RV) and best corrected visual acuity (BCVA) after intravitreal injection with respect to the VMI configuration on spectral-domain OCT using chi-squared test and repeated measures anova adjusted for confounding covariates epiretinal membrane, administered drug and subretinal fluid. Results Fifty-nine eyes of 53 patients (mean age: 47.4 ± 16.9 years) were included. VMI status had no effect on complete CME resolution rate (p = 0.16, corrected p-value: 0.32), time until resolution (p = 0.09, corrected p-value: 0.27) or CME relapse rate (p = 0.29, corrected p-value: 0.29). Change over time did not differ among the VMI configuration groups for BVCA (p = 0.82) and RV (p = 0.18), but CRT decrease was greater and faster in the posterior vitreous detachment (PVD) group compared to the posterior vitreous attachment (PVA) and vitreous macular adhesion (VMA) groups (p = 0.04). Also, the percentage of patients experiencing a ≥ 20% CRT thickness decrease after intravitreal injection was greater in the PVD group (83%) compared to the VMA (64%) and the PVA (16%) group (p = 0.027), however, not after correction for multiple testing (corrected p-value: 0.11). Conclusion The VMI configuration seems to be a factor contributing to treatment efficacy in uveitic CME in terms of CRT decrease, although BCVA outcome did not differ according to VMI status.

Original languageEnglish (US)
Pages (from-to)e561-e567
JournalActa Ophthalmologica
Issue number7
StatePublished - Nov 1 2015


  • cystoid macular oedema
  • intravitreal therapy
  • macular oedema
  • optical coherence tomography
  • posterior vitreous attachment
  • triamcinolone
  • uveitis
  • vitreomacular adhesion
  • vitreomacular traction

ASJC Scopus subject areas

  • Ophthalmology


Dive into the research topics of 'Influence of the vitreomacular interface on the efficacy of intravitreal therapy for uveitis-associated cystoid macular oedema'. Together they form a unique fingerprint.

Cite this